n.hartmann

TL2 Moderator · Palermo

Contributes reviews on supplier material. Based in Palermo.

Joined 17 November 2024 · last posted 1d

96Posts here

2Topics

1Solutions

112Likes received

118Likes given

21Badges

92Days visited

1kPosts read

Recent activity

Full stream

Packaging that arrived damaged: documenting it properly Replied, post #50 · Sourcing › Logistics · 27 Jul 2026 · 31 likes Picking up post #47: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
The five documentation pages worth reading before you post anything — a second dataset Replied, post #3 · marked as the solution · Start Here › Welcome · 27 Jul 2026 · 26 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #66 · Compounds › Repair & healing peptides · 25 Jul 2026 · 2 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #31 · Lounge › Off topic · 22 Jul 2026 · 1 like I read post #29 twice before replying, because I had assumed the opposite. Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #38 · Compounds › Retatrutide · 18 Jul 2026 · 1 like TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #110 · Evidence › Journal club · 16 Jul 2026 · 0 likes Coming back to post #108, because the follow-up matters more than the original answer. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide,…
How shortages have affected compounding permissions Replied, post #38 · Access › Shortages · 14 Jul 2026 · 4 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #51 · Clinical › Comorbidities · 13 Jul 2026 · 9 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
Follow-up: Reading an interaction checker output critically Replied, post #43 · Practice › Interactions · 12 Jul 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #57 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 1 like post #56 answers the question as asked. The question underneath it is different. Gradient slope is the single biggest driver of apparent purity differences. A shallower…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #29 · Compounds › Secretagogues & GH axis · 8 Jul 2026 · 0 likes I read post #27 twice before replying, because I had assumed the opposite. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #60 · Access › International · 6 Jul 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…